Latest news with #IWCapital
Sky News
10-06-2025
- Business
- Sky News
Recycling firm seeks Impact with £3m IW Capital investment
A plastic recycling business which counts Nestle, the Swiss consumer goods giant, among its backers, will this week unveil a multimillion pound capital injection from one of its key shareholders. Sky News understands that Impact Recycling, which uses a complex process to separate mixed plastic waste into 'high-purity' output, has struck a deal to secure £3.3m from existing venture capital backer IW Capital. Impact Recycling, which has received a grant from the government agency Innovate UK and a £7m loan from Nestle, counts the NHS as a major customer at its Glasgow site, where it recycles medical plastic waste. The company is also backed by LG Chem, Korea's biggest chemical company, reflecting the growing demand among global industrial groups for more sustainable environmental solutions to their manufacturing processes. IW Capital's latest investment comes during a period of significant regulatory change, including in the form of the EU's Plastic Packaging and Plastic Packaging Waste Directive, which mandates 35% recycled content to be used in any plastic packaging by 2030. That figure will rise to 60% by 2040, posing a major industrial challenge. David Walsh, CEO of Impact Recycling, said: "With strong demand from global partners and our licensing model gaining traction, we're well-positioned to scale our operations." The new capital is to be used in part to expand Impact Recycling's operations to new markets. "Impact Recycling exemplifies the kind of business we're proud to support-deeply innovative, commercially proven, and playing a critical role in the future of sustainable materials," Alan Armstrong, chairman of IW Capital, said.
Sky News
11-03-2025
- Health
- Sky News
Digital therapeutics group Strolll lands tonic of £10m funding boost
A digital therapeutics start-up which uses augmented reality (AR) glasses to aid people suffering from disorders including Parkinson's disease and multiple sclerosis will this week announce a £10m funding injection. Sky News understands that Strolll, which was founded five years ago, has secured the new capital in a round led by IW Capital, which has backed other fast-growing UK SMEs including Daily Dose and Transcend Packaging. Strolll assists patients by using specially developed games to enliven physiotherapy exercises, in both clinical and residential environments. The company says that its clinical trials have shown that clinicians using its technology are able to offer up to seven times the level of treatment while utilising two-thirds less staff time, allowing healthcare services to provide patient care more effectively and efficiently. Strolll said on Tuesday that it would use its new investment to accelerate sales and marketing activities, extend its product range, and to target additional neuro-related disorders. Last year, it commenced a three-year, £2.4m project grant-funded by the National Institute for Health and Care Research with the University of Leeds, University of York and four leading NHS trusts to conduct a randomised controlled trial of Strolll as a therapeutic treatment for patients with Parkinson's disease. It also entered the US market in a $3m collaboration with US healthcare provider Cleveland Clinic, with the latter becoming a shareholder in Strolll. Strolll's latest funding comes as an ageing population means that neurological disorders such as Parkinson's disease are becoming increasingly prevalent. "Strolll is transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives," said Isobel Egemole, IW Capital's investment director.
